BVF:FRA
Bausch Health Companies Inc
7,24 €
arrow_upward
+1,54%(+0,11) 1D
6-ноя., 22:00:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BVF...
Open
6,76 €
High
7,24 €
Low
6,76 €
Mkt. cap
3,08 млд
Avg. vol.
198,00
Volume
0,00
52-wk high
7,99 €
52-wk low
3,66 €
No. of employees
20 миң
Open
6,76 €
High
7,24 €
Low
6,76 €
Mkt. cap
3,08 млд
Avg. vol.
198,00
Volume
0,00
52-wk high
7,99 €
52-wk low
3,66 €
No. of employees
20 миң
News stories
From web sources and news partners
Investing.com
·
17 саат мурун
Bausch Health presents data on alcohol-associated hepatitis
Yahoo Finance
·
17 саат мурун
Bausch Health's Gastroenterology Business, Salix, to Present New Data on Cirrhosis Trends and Severe Alcohol-Associated Hepatitis at The Liver Meeting® 2026
Yahoo! Finance Canada
·
2 күн мурун
BHC Q3 Earnings Call Highlights Raised Outlook, Xifaxan Risks
Yahoo! Finance Canada
·
3 күн мурун
What in the World Happened With Bausch Health Stock Last Week?
Profile
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20,3 миң
Founded1960
HeadquartersЛаваль, Квебек, Канада
SectorHealth Care
IndustryPharmaceutical industry
Websitebauschhealth.com